US4013074A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Implantable medication-dispensing device
Assignee: Individual
•
Filing: 1976-04-06
•
Granted: 1977-03-22
•
Expires: 1996-04-06
Abstract
Abstract This invention is directed to an implantable medication-dispensing device which is arranged for subcutaneous implantation. The device has hard body in which is located a liquid reservoir, an adjacent gas chamber, and a pump which is manually operable through the cutaneous layer for drawing liquid medication from the reservoir and dispensing it and directing it into the body tissue below the hypoderm. A refill membrane permits injection of medication into the reservoir so that the implanted device can be periodically refilled.
Inventors
- 👤 George G. Siposs
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 02:24
CPC Classifications
A; A61; A61M; A61M5/00; A61M5/14; A61M5/142; A61M5/14244; A61M5/14276; A61M5/1428; F; F04; F04B; F04B43/00; F04B43/12; F04B43/1253; A61M2209/00; A61M2209/04; A61M2209/045; A61M5/14212; A61M5/14232
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
390 words
An implantable insulin medication-dispensing device comprising: a substantially rigid body having a top directed toward the skin and having a bottom directed toward subcutaneous tissue when implanted and having opposed sides; a chamber in said body having a movable diaphragm member therein to separate said chamber into an insulin reservior and gas chamber; a refill port in the top of said body connected to said medication reservoir, said refill chamber having resilient plug to permit transcutaneous hypodermic injection of liquid insulin medication from the exterior of the device through said refill port into said reservoir; a chamber port in the top of said body connected to said chamber, said chamber having a resilient plug to permit transcutaneous hypodermic injection of gas from the exterior of the device through said port into said gas chamber to control gas pressure in said chamber and to measure gas pressure in said chamber; an insulin medication-dispensing pump connected to said medication volume of said reservoir to cause periodic flow of liquid insulin medication out of said reservoir when said device is actuated, said insulin medication-dispensing pump having a pump chamber having an inlet and an outlet such that actuation of said pump causes flow of liquid insulin, an outlet check valve at the outlet termination of said pump chamber outlet directed out of said bottom so that insulin discharge from said outlet check valve discharges insulin out of said medication-dispensing device directly to subcutaneous body tissue to prevent draining of the pump or pump outlet between pumping periods and prevent body tissue from growing into said dispensing pump outlet; and actuation means connected to said pump for discharging medication from said insulin dispensing device, said actuation means being a manually accessible thrustor so positioned on one of said sides of said body that said thrustor can be transcutaneously manually actuated by transcutaneously manually grasping said opposed sides and actuating said thrustor for actuating said pump for dispensing insulin into the body upon physiological demand, said insulin reservoir, said gas chamber, said refill port, said chamber port, said medication-dispensing port, and said manually accessible thrustor all being mounted in said substantially rigid body so that actuation of said pump to discharge medication does not cause reduction in external volume of said substantially rigid body as a result of reduction in insulin volume in said reservoir.
Claim 2
Dependent Claim
390 words
An implantable insulin medication-dispensing device comprising: a substantially rigid body having a top directed toward the skin and having a bottom directed toward subcutaneous tissue when implanted and having opposed sides; a chamber in said body having a movable diaphragm member therein to separate said chamber into an insulin reservior and gas chamber; a refill port in the top of said body connected to said medication reservoir, said refill chamber having resilient plug to permit transcutaneous hypodermic injection of liquid insulin medication from the exterior of the device through said refill port into said reservoir; a chamber port in the top of said body connected to said chamber, said chamber having a resilient plug to permit transcutaneous hypodermic injection of gas from the exterior of the device through said port into said gas chamber to control gas pressure in said chamber and to measure gas pressure in said chamber; an insulin medication-dispensing pump connected to said medication volume of said reservoir to cause periodic flow of liquid insulin medication out of said reservoir when said device is actuated, said insulin medication-dispensing pump having a pump chamber having an inlet and an outlet such that actuation of said pump causes flow of liquid insulin, an outlet check valve at the outlet termination of said pump chamber outlet directed out of said bottom so that insulin discharge from said outlet check valve discharges insulin out of said medication-dispensing device directly to subcutaneous body tissue to prevent draining of the pump or pump outlet between pumping periods and prevent body tissue from growing into said dispensing pump outlet; and actuation means connected to said pump for discharging medication from said insulin dispensing device, said actuation means being a manually accessible thrustor so positioned on one of said sides of said body that said thrustor can be transcutaneously manually actuated by transcutaneously manually grasping said opposed sides and actuating said thrustor for actuating said pump for dispensing insulin into the body upon physiological demand, said insulin reservoir, said gas chamber, said refill port, said chamber port, said medication-dispensing port, and said manually accessible thrustor all being mounted in said substantially rigid body so that actuation of said pump to discharge medication does not cause reduction in external volume of said substantially rigid body as a result of reduction in insulin volume in said reservoir.
Claim 3
Dependent Claim
44 words
The implantable insulin medication-dispensing device of claim 1 wherein a palpable finger-engaging notch is provided in the side of said device opposite said actuation means so that transcutaneous manual grasping of said device comprises engagement with said notch and with said manually accessible thrustor.
Claim 4
Dependent Claim
68 words
The implantable insulin medication-dispensing device of claim 1 wherein said manually accessible thrustor is a lever having two ends which are manually accessible so that pressing one end of said lever causes advance of said pump to pump medication and depressing the other end of said lever causes resetting for subsequent advance of said pump so that said lever must be alternately actuated to cause excessive pump actuation.
Claim 5
Dependent Claim
28 words
The implantable medication-dispensing device of claim 3 wherein said lever is pivoted between its ends and said lever extends out beyond one of said sides of said device.
Claim 6
Dependent Claim
43 words
The implantable medication-dispensing device of claim 4 wherein a palpable finger-engaging notch is provided in the side of said device opposite said actuation means so that transcutaneous manual grasping of said device comprises engagement with said notch and with said manually accessible thrustor.
Claim 7
Dependent Claim
80 words
The implantable insulin medication-dispensing device of claim 1 wherein said pump is a peristaltic pump having a flexible tubing therein and said discharge check valve has a crossed bore therein, with said flexible tubing extending over said crossed bore so that pressure in said tubing expands said tubing over said crossed bore to permit flow of medication from said tubing through said outlet check valve, said outlet check valve being located in a port in said bottom of said device.
Claim 8
Dependent Claim
102 words
The implantable insuling medication-dispensing device of claim 6 wherein said outlet check valve has an inlet bore in communication with said tube, and first and second cross bores and an outlet bore, said first cross bore being in communication with said inlet bore and said second cross bore being in communication with said outlet bore, said flexible tubing covering both of said cross bores so that insulin under pressure flows from said inlet bore, through said first cross bore, inside the expanded tubing, and to said second cross bore and thence jets out of said outlet bore into tissue below the skin.
Claim 9
Dependent Claim
44 words
The implantable medication-dispensing device of claim 1 wherein said movable member in said chamber is a resilient diaphragm separating the liquid medication-containing reservoir from the closed gas chamber, said diaphragm flexing as medication is withdrawn from the medication-containing portion of said reservoir for dispensing.
References Cited (Backward Citations)
US2795245A
Cited
US3310051A
Cited
US3492996A
Cited
US3542022A
Cited
US3527220A
Cited
US3731681A
Cited
US3692027A
Cited
US3923060A
Cited
US3951147A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1980-03-21 | 1980-09-20 | 1981-03-22 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1984-03-21 | 1984-09-20 | 1985-03-22 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1988-03-21 | 1988-09-20 | 1989-03-22 | $7700.00 | Window Closed / Lapsed |